Form 4 for GILD Gilead Sciences

Accepted 2026-06-11 18:32:47 ET · period of report 2026-06-10 · accession 0001310204-26-000018 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2026-06-11 18:32	2026-06-10	GILD	Dickinson Andrew D	CFO	M - OptEx	—	+2,796	176.0K	+2%	—
D	2026-06-11 18:32	2026-06-10	GILD	Dickinson Andrew D	CFO	F - Tax	$121.48	-1,341	174.6K	-0.8%	-$162.9K
D	2026-06-11 18:32	2026-06-10	GILD	Dickinson Andrew D	CFO	M - OptEx	—	-2,796	27.9K	-9%	—

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2026-06-10	M	A	2,796	—	175,987	D	—	—	(F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
2	Common	Common Stock	2026-06-10	F	D	1,341	$121.48	174,646	D	—	—
3	Derivative	Restricted Stock Unit	2026-06-10	M	D	2,796	—	27,851	D	— · — to —	2,796 Common Stock	(F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F2) The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested. (F2) The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested.